NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Red Queen Bio

Red Queen Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.redqueen.bio/

Last Round

Seed

Nov 14, 2025

Est. Valuation

$22.5M

Total Funding Raised

$15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Red Queen Bio is a biotechnology company that develops biosecurity technology to defend against emerging biological threats enabled by artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug discoverybiotechnologytherapeutic discoveryAI drug discoveryantibody discoverybiodefenselab automationdrug resistancein silico drug designbiosecurityreinforcement learningmodel-in-the-loopfrontier AI labbiotech R&Dcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Red Queen Bio Comparables

Compare Red Queen Bio with similar companies based on industry and business-model similarity.

Red Queen Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Red Queen Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 14, 2025

Key People

Founding team and executive leadership

Nicole Camfield

Chief Operating Officer

Executive Team

Red Queen Bio Investors

Notable investors and investment history

Red Queen Bio investors
InvestorRounds
Cerberus VenturesSeed
Halcyon VenturesSeed
LongeVCSeed
Fifty YearsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Grew 30% QoQ from 10 to 13 employees.

Red Queen Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Red Queen Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Red Queen Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range13
Year Founded2025
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.